Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 698 43 552.4 |
96 | EP file number | EAKZ | 04 07 5775.9 |
97 | EP publication number | EPN | 1431311 |
54 | Designation/title | TI | Immunotherapie von B-Zellen Krebs mit einer Kombination von Anti-CD22 und Anti-CD20 Antikörpern |
51 | IPC main class | ICM (ICMV) | C07K 16/28 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 39/395 (2006.01), A61P 35/00 (2006.01) |
22 | DE application date | DAT | Mar 17, 1998 |
96 | EP application date | EAT | Mar 17, 1998 |
43 | Date of first publication | OT | Jun 23, 2004 |
| Date of publication of grant | PET | Jul 20, 2016 |
71/73 | Applicant/owner | INH | Immunomedics, Inc., Morris Plains, N.J., US |
72 | Inventor | IN | Goldenberg, David M., MendhamNJ 07945, US |
74 | Representative | VTR | bohmann, 80335 München, DE |
| Address for service | | bohmann Dr. Armin K. Bohmann, 80335 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 41506 P Mar 24, 1997
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000001431311 Searchable text:
EP000001431311 Original document:
EP000001431311B1 Searchable text:
EP000001431311B1 |
43 | Date of first publication | EVT | Jun 23, 2004 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 7, 2024 (Show all update days)(Hide all update days)- Jan 7, 2024; Mar 20, 2018; Aug 3, 2017; Jun 30, 2017; Apr 4, 2017; Jan 24, 2017; Jul 29, 2016; Jul 21, 2016; Jul 2, 2015; Jan 26, 2013
- Historical data not available for this/these date(s)
- May 26, 2011
- Date of the first transfer into DPMAregister
|